Ifosfamide and vincristine in paediatric tumours. A phase II study
European Paediatric Haematology and Oncology · 1984
DOI: 10.3109/08880018409141708 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Paediatric Haematology and Oncology, 1984. Verfasst von J de Kraker und 1 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
In 25 patients previously treated extensively, ifosfamide with vincristine was used as last resource. Toxicity and antitumour effect were studied. All patients vomited. Haematuria and pancytopenia for more than one week were the main side effects. Thirteen patients responded. Six had a complete response. Four of these are now off therapy. Even although cyclophospha-mide was used in previous protocols, seven out of fourteen patients responded.
Zitieren
APA
Kraker, J. D., & Voute, P. (1984). Ifosfamide and vincristine in paediatric tumours. A phase II study. European Paediatric Haematology and Oncology. https://doi.org/10.3109/08880018409141708
Vancouver
Kraker JD, Voute P. Ifosfamide and vincristine in paediatric tumours. A phase II study. European Paediatric Haematology and Oncology. 1984. doi:10.3109/08880018409141708
BibTeX
@article{Kraker1984,
author = {Kraker, J de and Voute, Pa},
title = {Ifosfamide and vincristine in paediatric tumours. A phase II study},
journal = {European Paediatric Haematology and Oncology},
year = {1984},
doi = {10.3109/08880018409141708}
}
EUVIMED